Clinical Trials Browser

Margins of Excision × Thoracic × Clear all

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04073745 2026-02-04

Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer

Phase 1 Active not recruiting

50 enrolled

Thoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07242053 2025-11-21

Margin Intraoperative CT Feedback Feedback Study

Phase NA Active not recruiting

80 enrolled

Thoracic

Margins of Excision, Disease, Lung Neoplasms

NCT06405815 2024-05-09

A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer

Completed

200 enrolled

Thoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung

NCT05881057 2023-05-30

Application of SERS Technology Based Intraoperative Navigation System in Lung Cancer

Not yet recruiting

200 enrolled

Thoracic

Margins of Excision, Lung Neoplasms

NCT01460134 2018-01-31

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Phase 1 Completed

90 enrolled

DermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmThoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer

Margin Intraoperative CT Feedback Feedback Study

A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer

Application of SERS Technology Based Intraoperative Navigation System in Lung Cancer

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers